On Monday, Pfizer Inc (NYSE: PFE) opened lower -0.86% from the last session, before settling in for the closing price of $24.47. Price fluctuations for PFE have ranged from $20.92 to $31.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -13.25%. Company’s average yearly earnings per share was noted -3.68% at the time writing. With a float of $5.67 billion, this company’s outstanding shares have now reached $5.68 billion.
Considering the fact that the conglomerate employs 81000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 67.39%, operating margin of 23.65%, and the pretax margin is 11.83%.
Pfizer Inc (PFE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Pfizer Inc is 0.18%, while institutional ownership is 67.02%. The most recent insider transaction that took place on May 23 ’25, was worth 1,380,632. Before that another transaction happened on May 05 ’25, when Company’s Former Officer proposed sale 55,000 for $23.87, making the entire transaction worth $1,312,736.
Pfizer Inc (PFE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -3.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.22% during the next five years compared to -13.25% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Check out the current performance indicators for Pfizer Inc (PFE). In the past quarter, the stock posted a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21. Likewise, its price to free cash flow for the trailing twelve months is 12.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.38, a number that is poised to hit 0.58 in the next quarter and is forecasted to reach 3.08 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Compared to the last year’s volume of 45.68 million, its volume of 43.21 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 4.41%.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 52.89%, which indicates a significant increase from 0.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.49 in the past 14 days, which was lower than the 0.55 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.00, while its 200-day Moving Average is $25.52.
